CCN1 and breast cancer: Since CYR61 expression is regulated by hypoxia and undergoes alternative splicing itself in breast cancer [47], we hypothesized that CYR61 KD also could disrupt the balance of splicing regulation by shifting the splicing landscape away from producing variants such as AR-V7.